(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ZEINCRO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ZEINCRO

ST13

US500000085035372

Class

35, 41, 42

Filing

85035372

Registration

3983984

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

10/28/2021

Trademark type

Word

Nice classes

35, 41, 42

Filing date

05/11/2010

Registration date

06/28/2011

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/28/2021

Last transaction

10/28/2021

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

1998-00-00

First use in commerce

2008-09-00

Drawing code

4

Owner type

24

Owner location

LONDON, GB

Examiner

SPRUILL, DARRYL M

Law office

M30

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

ZEIN BIOTEC LIMITED
Sivolapenko, Grigorios

Representatives

B. Brett Heavner FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER, LL

Technical classification

Nice Classes

Class 35Class 41Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Providing technical and business consulting services and management servicesclinical data and regulatory submission management to medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval

Class 41

Educational servicesproviding training seminars and congresses in the field of clinical research

Class 42

Conducting research and clinical trials relating to pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Publications

History of USPTO decisions and trademark events.

28 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

10/28/2021

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

10/28/2021

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/28/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/28/2021

E89R

TEAS SECTION 8 & 9 RECEIVED

06/15/2021

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

07/01/2020

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

06/28/2020

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

01/20/2018

C15P

REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

01/20/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/20/2018

E815

TEAS SECTION 8 & 15 RECEIVED

12/27/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

06/28/2011

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/12/2011

PUBO

PUBLISHED FOR OPPOSITION

04/12/2011

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/09/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/07/2011

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/07/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/07/2011

ALIE

ASSIGNED TO LIE

02/23/2011

ALIE

ASSIGNED TO LIE

02/22/2011

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/15/2011

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/23/2010

GNRT

NON-FINAL ACTION E-MAILED

08/23/2010

CNRT

NON-FINAL ACTION WRITTEN

08/23/2010

DOCK

ASSIGNED TO EXAMINER

08/23/2010

MPMK

NOTICE OF PSEUDO MARK MAILED

05/18/2010

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/17/2010

NWAP

NEW APPLICATION ENTERED

05/14/2010

Continuous trademark protection

Get notified about every new filing that threatens ZEINCRO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.